Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportClinical Research/R&D Search Results « » The Henry J. Kaiser Family Foundation

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Experimental Ebola Vaccine Safe, Elicits Immune Response, Researchers Say

Agence France-Presse: Ebola vaccine is safe, researchers say “Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the U.S. National Institutes of Health suggest it is safe for use, researchers said Wednesday…” (1/28). Press Association/The Guardian: Cautious optimism follows results from trials of early…

Experts Debate Role Of Public-Private Partnerships In Vaccine, Drug Development

GroundTruth Project/GlobalPost: In Ebola response, Big Pharma and public sector strive to make up for lost time “…The delayed response [to Ebola] is an example of the diverging interests of public and private sectors when it comes to addressing a public health crisis, say experts from both sides. … Still,…

Experts At European Parliament Session Outline Challenges In TB Drug Development

EurActiv: Developing countries urged to produce TB vaccines locally “Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease. Speaking at the European Parliament on Wednesday (21…